Table 2.
Univariate and multivariate analyses for the clinicopathological correlates.
| variables | Aggressiveness | univariate analysis | ||
|---|---|---|---|---|
| Yes(n=24) | No(n=38) | χ 2 | p-value | |
| age (years) | ||||
| ≤37.6 | 13 | 18 | 0.272 | 0.602 |
| >37.6 | 11 | 20 | ||
| gender | ||||
| Male | 14 | 17 | 1.088 | 0.297 |
| Female | 10 | 21 | ||
| Tumor size(cm3) | ||||
| ≤9.85 | 17 | 14 | 6.798 | 0.009 |
| >9.85 | 7 | 24 | ||
| Preoperative serum | ||||
| GH level(ng/ml) | ||||
| ≤26.5 | 16 | 15 | 4.351 | 0.037 |
| >26.5 | 8 | 23 | ||
| PTTG1 | ||||
| High | 18 | 13 | 19.789 | 0.002 |
| Low | 6 | 25 | ||
| SYT1 | ||||
| High | 16 | 15 | 4.351 | 0.037 |
| Low | 8 | 23 | ||
GH: growth hormone
High: The positive percent of PTTG1 or SYT1 is equal or more than 50%. Low: The nuclear-positive percent of PTTG1 or SYT1 is less than 50%.